InvestorsHub Logo
Followers 17
Posts 2021
Boards Moderated 0
Alias Born 02/26/2011

Re: Investaholic33 post# 5039

Tuesday, 02/25/2014 5:22:23 AM

Tuesday, February 25, 2014 5:22:23 AM

Post# of 106839
Yes, that is the study i was referring to. However, I expected the news of this huge study to do far more than draw attention to the use of stem cells in regenerative heart medicine.

The name of the study is "The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all cause mortality in acute myocardial infarction," and uses bone marrow stem cells to prolong life.

Therefore, i was thinking that they would need the kind of specialized needles that BHRT makes to deliver the stem cells to the hearts of these patients. I was hoping that BHRT would actually play a role in the study, with their needles.

Of course, it is highly ironic that Mr Tomas, himself, has just had open heart surgery and might be receiving the very stem cell treatment that he helped develop. Wouldn't it be great if needles from his own company were used to save him?!

Any thoughts?